Latest receivables for OXFD: $11M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Oxford Immunotec Global PLC (OXFD) currently reports a receivables of $11M as of September 2020. That compares with $24M in the prior-year period — down 54.3% year over year. Use the charts on this page to explore Oxford Immunotec Global PLC's receivables history and peer comparisons.
Oxford Immunotec Global PLC's receivables decreased from $24M to $11M — a 54.3% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Oxford Immunotec Global PLC reported $11M in receivables as of September 2020. That compares with $24M in the prior-year period — down 54.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Oxford Immunotec Global PLC, and consider following OXFD for alerts when major investors trade the stock.
Oxford Immunotec Global PLC is classified in the Healthcare sector. On receivables, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OXFD with unrelated industries.